These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19835720)

  • 1. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.
    Arribas-Mir L; Rueda-Lozano D; Agrela-Cardona M; Cedeño-Benavides T; Olvera-Porcel C; Bueno-Cavanillas A
    Contraception; 2009 Nov; 80(5):457-62. PubMed ID: 19835720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
    Riney S; O'Shea B; Forde A
    Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
    Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
    J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive implants.
    Ladipo O; Coutinho EM
    Curr Opin Obstet Gynecol; 1994 Dec; 6(6):564-9. PubMed ID: 7893965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and clinical safety of Implanon.
    Blumenthal PD; Gemzell-Danielsson K; Marintcheva-Petrova M
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():29-36. PubMed ID: 18330815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement.
    Mark A; Sonalkar S; Borgatta L
    Contraception; 2013 Nov; 88(5):619-23. PubMed ID: 23790436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding related to etonogestrel subdermal implant in a US population.
    Casey PM; Long ME; Marnach ML; Bury JE
    Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The introduction of a new contraceptive; two years experience with Norplant.
    Davie J; Hiremath K; Glasier A
    Health Bull (Edinb); 1996 Jul; 54(4):314-7. PubMed ID: 8783485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
    Flores JB; Balderas ML; Bonilla MC; Vázquez-Estrada L
    Int J Gynaecol Obstet; 2005 Sep; 90(3):228-33. PubMed ID: 16043175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.
    Yildizbas B; Sahin HG; Kolusari A; Zeteroglu S; Kamaci M
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):248-52. PubMed ID: 17763263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
    Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
    Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-abortion contraception with etonogestrel subdermal implant.
    Barros Pereira I; Carvalho RM; Graça LM
    Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():33-5. PubMed ID: 25522115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women.
    Sivin I; Croxatto H; Bahamondes L; Brache V; Alvarez F; Massai R; Schechter J; Ranta S; Kumar N; Wu E; Tejeda AS; Reyes V; Travers E; Allen A; Moo-Young A
    Contraception; 2004 Feb; 69(2):137-44. PubMed ID: 14759619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
    Wilson S; Tennant C; Sammel MD; Schreiber C
    Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M; Guarnaccia M; Alon J; Wiley J
    Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.